204079-15-2 Usage
Uses
Used in Organic Synthesis:
2-(Cyclobutylamino)benzonitrile is utilized as a key intermediate in organic synthesis for the production of a variety of complex organic molecules. Its unique structure allows for the formation of diverse chemical entities, contributing to the advancement of chemical research and development.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(Cyclobutylamino)benzonitrile is employed as a starting material for the development of new drugs. Its potential in medicinal chemistry is attributed to its ability to be modified and incorporated into drug candidates, potentially leading to novel therapeutic agents.
Used in Agrochemical Development:
2-(Cyclobutylamino)benzonitrile also finds application in the agrochemical sector, where it is used as a precursor in the synthesis of new agrochemicals. Its role in this industry is crucial for the development of innovative products aimed at enhancing agricultural productivity and crop protection.
Used in Materials Science:
In the field of materials science, 2-(Cyclobutylamino)benzonitrile is leveraged for the synthesis of advanced materials with specific properties. Its versatility in molecular construction allows for the engineering of materials with tailored characteristics for various applications, such as in electronics, coatings, or other high-tech industries.
Check Digit Verification of cas no
The CAS Registry Mumber 204079-15-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,0,7 and 9 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 204079-15:
(8*2)+(7*0)+(6*4)+(5*0)+(4*7)+(3*9)+(2*1)+(1*5)=102
102 % 10 = 2
So 204079-15-2 is a valid CAS Registry Number.
204079-15-2Relevant academic research and scientific papers
Wang, Jiang,Zheng, Nan
, p. 11424 - 11427 (2015)
We report the first example of an intermolecular [4+2] annulation of cyclobutylanilines with alkynes enabled by visible-light photocatalysis. Monocyclic and bicyclic cyclobutylanilines successfully undergo the annulation with terminal and internal alkynes to generate a wide variety of amine-substituted cyclohexenes including new hydrindan and decalin derivatives with good to excellent diastereoselectivity. The reaction is overall redox neutral with perfect atom economy.
Method of inhibiting neoplastic cells with imidazoquinazoline derivatives
-
, (2008/06/13)
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to imidazoquinazoline derivatives.
Imidazoquinazoline derivatives
-
, (2008/06/13)
PCT No. PCT/JP97/03023 Sec. 371 Date Apr. 27, 1998 Sec. 102(e) Date Apr. 27, 1998 PCT Filed Aug. 29, 1997 PCT Pub. No. WO98/08848 PCT Pub. Date Mar. 5, 1998Imidazoquinoline derivatives of the formula (wherein X may be O or S) provide selective cyclic guanosine 3',5' monophosphate (cGMP)-specific phosphodiesterase (PDE) inhibitory activity. The compounds are useful for treating or ameliorating cardiovascular disease such as thrombosis, angina pectoris, hypertension, heart failure and arterial sclerosis, as well as asthma, impotence and the like.
